Xavitas Injection is a potent antibiotic formulation that combines Ceftazidime (2gm) and Avibactam (500mg) to effectively combat a range of bacterial infections. This combination is particularly valuable in treating infections caused by multidrug-resistant organisms, making it a critical option in modern antimicrobial therapy. Ceftazidime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Avibactam is a beta-lactamase inhibitor that protects Ceftazidime from degradation by certain enzymes produced by resistant bacteria. Together, they enhance the efficacy of the treatment, providing a robust defense against infections such as complicated urinary tract infections, intra-abdominal infections, and pneumonia. Xavitas Injection is typically administered intravenously in a clinical setting, ensuring that patients receive the necessary dosage for optimal therapeutic effect.